Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Venous Thromboembolism 4Venous Thrombosis 2Pulmonary Embolism 2Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thrombosis 1Thromboembolism 1Sarcoma 1Ovarian Neoplasms 1Lung Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Enoxaparin 4Saline Solution 3Warfarin 2Tinzaparin 2Dalteparin 2Aspirin 2enoxaparin sodium 1edoxaban 1alvocidib 1Watchful Waiting 1Tranexamic Acid 1Sodium Chloride 1Sodium Bicarbonate 1Nadroparin 1Lenalidomide 1Ketoconazole 1Immunoenzyme Techniques 1High-Energy Shock Waves 1Heparin, Low-Molecular-Weight 1Heparin 1Gemcitabine 1Fondaparinux 1Fluorodeoxyglucose F18 1Fluoridation 1Estramustine 1Enzyme-Linked Immunosorbent Assay 1Doxorubicin 1Docetaxel 1Clopidogrel 1Bleeding Time 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thromboembolism × Fondaparinux × Clear all
NCT00381888 2017-12-28

Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
44 enrolled 7 charts
GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Thromboembolism, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡